Background and objectives: Drug courts provide an array of substance use treatments and community-based services for probationers struggling with substance use disorders. We assessed substance use treatment services utilization...
Substance use disorders are common among justice-involved populations, the majority of whom are under community supervision in the form of probation. Substance involvement can amplify the challenges of complying with requirements...
Screening, brief intervention, and referral to treatment (SBIRT) is an evidence-based practice that has been shown to reduce alcohol and drug use in healthcare, educational, and other settings, but research on the...
Background: Addictive disorders are significant global public health burdens. Treatment uptake with these disorders is low and outcomes can be mixed. Electronic screening, brief intervention, and referral to treatment (e-SBIRT)...
To test the efficacy of a brief intervention to reduce alcohol or drug use and to promote use of addiction services among patients seeking mental health treatment.
A multi-centre, longitudinal, two-group...
Screening and brief intervention (SBI), effective in community health care, show inconsistent results in correctional settings (CS). We hypothesized that SBI needs adaptation for the incarcerated population. The study...
As part of the formative phase of screening and brief interventions (SBIs) for substance use amongst patients presenting for emergency services in South Africa, the present study explored health care providers’ attitudes and...
Screening, brief intervention and referral to treatment (SBIRT) programmes have resulted in generally positive outcomes in healthcare settings, particularly for problem alcohol use, yet implementation is hampered by...
Screening, brief intervention, and referral to treatment (SBIRT) for risky substance use is infrequently included in routine healthcare in low-resourced settings. A SBIRT programme, adopted by the Western Cape...
Substance use disorders co-occurring with other mental health disorders are common and harmful. Clinical guidelines often recommend substance use screening and brief intervention though evidence about...
• Scoping review found inconsistent support for SBIRT for cannabis.
• Use of cannabis-specific screening could increase engagement.
• Modifications to brief interventions yielded inconsistent outcomes.
• Limited research has...
Background: Screening, brief intervention, and referral to treatment (SBIRT) is an evidence-based practice that has been shown to reduce alcohol and drug use in healthcare, educational, and other settings, but research on the...
INTRODUCTION
Nearly all chronic substance users enter the criminal justice system at some time in their use career. Drug use is closely associated with crime, and its prevalence among offenders is high (MacCoun et al., 2003; Newcomb et al...
ABSTRACT
We conducted a systematic review to examine the substance use and recidivism outcomes of prison-based substance use interventions. We searched public health, criminology, and psychology databases, and conducted forward and...
ABSTRACT
This study evaluated the planning, implementation, and preliminary outcomes of a US Bureau of Justice Assistance funded justice mental health focused reentry program for offenders with co-occurring substance use and mental health...
Abstract: This commentary argues the need to prioritize regulation and abstinence-based prevention and recovery as critical services in efforts to maximize the reduction of substance-related harm and the promotion of mental health at a...
Illicit drug markets operate through a complex, global chain—from production and trafficking to consumption and the profits that fuel organised crime. At every stage, these activities compromise the health and security of countries...
Background
Opioid-related overdose is the leading cause of mortality among individuals recently released from incarceration in the U.S. Naloxone is an FDA-approved opioid antagonist medication designed to rapidly reverse opioid...
The EU Drugs Strategy (2013–2020) set out a shared political framework to guide the European Union’s approach to drugs policy. Grounded in the principles of EU law and international conventions, it focused on protecting public health...
